{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:18:36Z","timestamp":1755217116159,"version":"3.43.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Gastrointestinal stromal tumor (GIST) with secondary thrombocytosis is a rare clinical case, exhibiting specificity in clinical diagnosis and treatment. We report a case of GIST with secondary thrombocythemia to raise clinicians\u2019 attention to this disease. On October 11, 2024, a 58-year-old male patient was admitted to the hospital due to \u201cintermittent right lower abdominal pain with increased bowel movements for more than 1\u202fmonth.\u201d The patient had no prior history of tumors, chronic inflammatory diseases, hematologic disorders or family history of genetic disorders. MRI-enhanced scans of the small intestine highly indicated a lymphoma of intestinal origin. Small bowel endoscopy and pathological biopsy revealed mild chronic inflammation of the intestinal mucosa, with intact villous architecture, no plasmacytosis, granulomas, or vasculitis, and no indication of GIST. Laboratory tests showed platelet count of 909\u202f\u00d7\u202f10<jats:sup>9<\/jats:sup>\/L, white blood cell count of 11.86\u202f\u00d7\u202f10<jats:sup>9<\/jats:sup>\/L, neutrophil ratio of 75.10%, lymphocyte ratio of 15.30% and hemoglobin 101\u202fg\/L. Bone marrow biopsy microscopically showed a normal number of megakaryocytes without abnormal aggregation and no myelofibrosis, suggesting there was no obvious hematologic malignancy and the thrombocytosis may have been secondary. The patient underwent partial resection of the small intestine and resection of mesenteric lesions on October 18, 2024. The intraoperative frozen section suggested a stromal tumor. The postoperative pathological biopsy suggested a GIST and genetic testing showed a mutation in the c-KIT gene (Exon 13). Postoperatively, the patient was treated with oral imatinib mesylate (400\u202fmg\/d) as adjunctive therapy. Three months after surgery, imaging showed no recurrence, platelet decreased and returned to normal levels.<\/jats:p>","DOI":"10.3389\/fmed.2025.1605819","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:24:13Z","timestamp":1754371453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal stromal tumor with secondary thrombocytosis: a case report of a high-risk patient"],"prefix":"10.3389","volume":"12","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e929575","DOI":"10.12659\/MSM.929575","article-title":"Contribution of interstitial cells of Cajal to gastrointestinal stromal tumor risk","volume":"27","author":"Wang","year":"2021","journal-title":"Med Sci Monit"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.6004\/jnccn.2022.0058","article-title":"NCCN guidelines\u00ae insights: gastrointestinal stromal tumors, version 2.2022","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/vetsci9070376","article-title":"Mutational analysis of c-KIT and PDGFRA in canine gastrointestinal stromal tumors (GISTs)","volume":"9","author":"Morini","year":"2022","journal-title":"Vet Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14309\/ajg.0000000000002100","article-title":"ACG clinical guideline: diagnosis and Management of Gastrointestinal Subepithelial Lesions","volume":"118","author":"Jacobson","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2169\/internalmedicine.9282-21","article-title":"Causes of thrombocytosis: a single-center retrospective study of 1,202 patients","volume":"61","author":"Edahiro","year":"2022","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.27216","article-title":"Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Tefferi","year":"2024","journal-title":"Am J Hematol"},{"volume-title":"Secondary thrombocytosis","year":"2024","author":"Rokkam","key":"ref7"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jama.2024.25349","article-title":"Essential thrombocythemia: a review","volume":"333","author":"Tefferi","year":"2025","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to Cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/13543784.2024.2318317","article-title":"KIT\/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem","volume":"33","author":"Cicala","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","article-title":"Gastrointestinal stromal tumors","volume":"36","author":"von Mehren","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/cas.16058","article-title":"Molecular and clinicopathological features of KIT\/PDGFRA wild-type gastrointestinal stromal tumors","volume":"115","author":"Nishida","year":"2024","journal-title":"Cancer Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.3390\/ijms21176218","article-title":"Thrombocytosis and effects of IL-6 Knock-out in a colitis-associated Cancer model","volume":"21","author":"Josa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jvim.16317","article-title":"Interleukin-6 and thrombopoietin concentrations in dogs with carcinoma with and without thrombocytosis","volume":"36","author":"Cheney","year":"2022","journal-title":"J Vet Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11912-025-01636-8","article-title":"Gastrointestinal stromal tumors","volume":"27","author":"Strauss","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/14737140.2017.1390431","article-title":"Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas","volume":"17","author":"Kose\u0142a-Paterczyk","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1055\/s-0044-1796630","article-title":"Regulatory effect of PDGF\/PDGFR on hematopoiesis","volume":"51","author":"Liu","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"114491","DOI":"10.1016\/j.biopha.2023.114491","article-title":"New insights about the PDGF\/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies","volume":"161","author":"Pandey","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jscr\/rjae497","article-title":"Jejunal gastrointestinal stromal tumor (GIST) with profound anemia","volume":"2024","author":"Huynh","year":"2024","journal-title":"J Surg Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","article-title":"New treatment strategies for advanced-stage gastrointestinal stromal tumours","volume":"19","author":"Klug","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/MOG.0000000000000584","article-title":"Gastrointestinal stromal tumor: epidemiology, diagnosis, and treatment","volume":"35","author":"Mantese","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.22.00294","article-title":"Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib (INTRIGUE): a randomized, open-label, phase III trial","volume":"40","author":"Bauer","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.21037\/jgo.2016.09.15","article-title":"Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review","volume":"8","author":"Oppelt","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"730213","DOI":"10.3389\/fmolb.2022.730213","article-title":"Rare c-KIT c.1926delA and c.1936T>G mutations in exon 13 define Imatinib resistance in gastrointestinal stromal tumors and melanoma patients: case reports and cell experiments","volume":"9","author":"Yan","year":"2022","journal-title":"Front Mol Biosci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41525-024-00405-z","article-title":"Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib","volume":"9","author":"Ingley","year":"2024","journal-title":"NPJ Genom Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"117690","DOI":"10.1016\/j.cca.2023.117690","article-title":"Tumor-educated platelets","volume":"552","author":"Najafi","year":"2024","journal-title":"Clin Chim Acta"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.thromres.2024.04.014","article-title":"Platelet Fc\u03b3RIIA: an emerging regulator and biomarker in cardiovascular disease and cancer","volume":"238","author":"Zhang","year":"2024","journal-title":"Thromb Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1605819\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:24:14Z","timestamp":1754371454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1605819\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1605819"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1605819","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"article-number":"1605819"}}